Ayman Oweida

1.9k total citations
46 papers, 1.3k citations indexed

About

Ayman Oweida is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ayman Oweida has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Ayman Oweida's work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (8 papers) and Axon Guidance and Neuronal Signaling (8 papers). Ayman Oweida is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (8 papers) and Axon Guidance and Neuronal Signaling (8 papers). Ayman Oweida collaborates with scholars based in United States, Canada and Australia. Ayman Oweida's co-authors include Sana D. Karam, Laurel B. Darragh, Shilpa Bhatia, David Raben, Eric T. Clambey, Lynn E. Heasley, David C. Binder, Benjamin Van Court, Andy V. Phan and Shelby Lennon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ayman Oweida

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayman Oweida United States	19	694	423	336	245	129	46	1.3k
Daniel Chua Hong Kong	22	671 1.0×	197 0.5×	823 2.4×	187 0.8×	449 3.5×	28	1.5k
Habib Sadeghirad Australia	7	509 0.7×	298 0.7×	238 0.7×	146 0.6×	82 0.6×	14	837
Simone Gaedicke Germany	18	497 0.7×	354 0.8×	362 1.1×	107 0.4×	137 1.1×	27	1.0k
Tomer Cooks Israel	18	621 0.9×	470 1.1×	965 2.9×	266 1.1×	517 4.0×	36	1.8k
Huimin Tian China	18	448 0.6×	360 0.9×	313 0.9×	166 0.7×	143 1.1×	34	1.0k
Hugo Arasanz Spain	20	1.3k 1.8×	940 2.2×	354 1.1×	251 1.0×	140 1.1×	57	1.8k
Nathan E. Reticker-Flynn United States	13	802 1.2×	826 2.0×	536 1.6×	132 0.5×	146 1.1×	24	1.5k
David R. Valdecanas United States	20	754 1.1×	457 1.1×	786 2.3×	273 1.1×	515 4.0×	33	1.6k
Meggy Suarez‐Carmona Belgium	16	624 0.9×	396 0.9×	509 1.5×	168 0.7×	331 2.6×	22	1.3k
Audrey Lupo France	20	1.7k 2.4×	1.5k 3.4×	597 1.8×	693 2.8×	322 2.5×	44	2.8k

Countries citing papers authored by Ayman Oweida

Since Specialization

Citations

This map shows the geographic impact of Ayman Oweida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Oweida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Oweida more than expected).

Fields of papers citing papers by Ayman Oweida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Oweida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Oweida. The network helps show where Ayman Oweida may publish in the future.

Co-authorship network of co-authors of Ayman Oweida

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Oweida. A scholar is included among the top collaborators of Ayman Oweida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Oweida. Ayman Oweida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diallo, Abou, et al.. (2025). Toll-like receptor 4 inhibition sensitizes non-small cell lung cancer to radiotherapy. Cancer Biology & Therapy. 26(1). 2590881–2590881.

Oweida, Ayman, et al.. (2024). Gingerol acts as a potent radiosensitizer in head and neck squamous cell carcinoma. Discover Oncology. 15(1). 553–553. 1 indexed citations

Paquette, Benoît & Ayman Oweida. (2024). Combination of radiotherapy and immunotherapy in duality with the protumoral action of radiation. Cancer/Radiothérapie. 28(5). 484–492.

Oweida, Ayman, et al.. (2023). Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities. Vaccines. 11(4). 818–818. 7 indexed citations

Knox, Aaron J., Benjamin Van Court, Ayman Oweida, et al.. (2023). A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease. Frontiers in Oncology. 13. 1105395–1105395. 3 indexed citations

Bickett, Thomas E., Michael W. Knitz, Miles Piper, et al.. (2021). Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC. Molecular Therapy. 30(3). 1149–1162. 6 indexed citations

Knitz, Michael W., Laurel B. Darragh, Thomas E. Bickett, et al.. (2021). Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma. Cancer Immunology Immunotherapy. 71(5). 1049–1061. 8 indexed citations

Young, Christian D., Li Bian, Kelsey Weigel, et al.. (2020). PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models. Clinical Cancer Research. 26(12). 3058–3070. 25 indexed citations

Oweida, Ayman, Adam C. Mueller, Miles Piper, et al.. (2020). Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunology Immunotherapy. 70(4). 989–1000. 27 indexed citations

10.

Bhatia, Shilpa, Ayman Oweida, Shelby Lennon, et al.. (2019). Inhibition of EphB4–Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers. Cancer Research. 79(10). 2722–2735. 38 indexed citations

11.

Karam, Sana D., Krishna Reddy, Patrick J. Blatchford, et al.. (2018). Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer. Clinical Cancer Research. 24(20). 4949–4959. 68 indexed citations

12.

Bhatia, Shilpa, Jaspreet Sharma, Sanjana Bukkapatnam, et al.. (2018). Inhibition of EphB4–Ephrin-B2 Signaling Enhances Response to Cetuximab–Radiation Therapy in Head and Neck Cancers. Clinical Cancer Research. 24(18). 4539–4550. 23 indexed citations

13.

Oweida, Ayman, Mohammad K. Hararah, Andy V. Phan, et al.. (2018). Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration. Clinical Cancer Research. 24(21). 5368–5380. 209 indexed citations

14.

Bhatia, Shilpa, Shelby Lennon, Ayman Oweida, et al.. (2018). Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor. Molecular Cancer Therapeutics. 17(9). 2049–2059. 9 indexed citations

15.

Sumner, Whitney, William A. Stokes, Ayman Oweida, et al.. (2017). Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy. Journal of Translational Medicine. 15(1). 168–168. 23 indexed citations

16.

Bhatia, Shilpa, Sanjana Bukkapatnam, Ayman Oweida, et al.. (2017). Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma. Cancer Cell International. 17(1). 41–41. 13 indexed citations

17.

Stokes, William A., David C. Binder, Bernard L. Jones, et al.. (2017). Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy. Journal of Neuroimmunology. 313. 118–122. 31 indexed citations

18.

Santos, Fabiano, George Shenouda, Kevin Petrecca, et al.. (2017). Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. Journal of Neuro-Oncology. 132(3). 419–426. 61 indexed citations

19.

Oweida, Ayman, Shilpa Bhatia, Todd M. Pitts, et al.. (2016). Ephrin‐B2 overexpression predicts for poor prognosis and response to therapy in solid tumors. Molecular Carcinogenesis. 56(3). 1189–1196. 33 indexed citations

20.

Oweida, Ayman, et al.. (2016). Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells. Cancer Biology & Therapy. 17(4). 390–399. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact